<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Seattle Breast Pathology Consultants &#187; Dr. Lawton&#8217;s Blog</title>
	<atom:link href="http://www.breastpathologyconsults.com/blog/category/dr_lawtons_blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.breastpathologyconsults.com/blog</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Tue, 29 Jun 2010 00:23:55 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Update on My Post:  Why is There No Consensus on How to Treat Some Diagnoses Found on Core Biopsy?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/why-is-there-no-consensus-on-how-to-treat-some-diagnoses-found-on-core-biopsy/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/why-is-there-no-consensus-on-how-to-treat-some-diagnoses-found-on-core-biopsy/#comments</comments>
		<pubDate>Sun, 13 Jun 2010 04:03:50 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[atypical lobular hyperplasia]]></category>
		<category><![CDATA[core biopsy]]></category>
		<category><![CDATA[flat epithelial atypia]]></category>
		<category><![CDATA[lobular carcinoma in situ]]></category>
		<category><![CDATA[papilloma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=481</guid>
		<description><![CDATA[I wrote an article a while back called &#8220;What Your Core Needle Biopsy Diagnosis Means&#8221; to help patients understand why sometimes even a &#8220;benign&#8221; diagnosis may require a surgical excision.  While writing that article, I spoke to many of my colleagues in breast pathology and breast imaging and found out that there is a marked [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/why-is-there-no-consensus-on-how-to-treat-some-diagnoses-found-on-core-biopsy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interesting Consensus Conference Report on Core Needle Biopsy of the Breast</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/interesting-consensus-conference-report-on-core-needle-biopsy-of-the-breast/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/interesting-consensus-conference-report-on-core-needle-biopsy-of-the-breast/#comments</comments>
		<pubDate>Fri, 19 Mar 2010 17:49:48 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[core biopsy]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=651</guid>
		<description><![CDATA[In the current issue of Cancer (April 1), there is a an interesting news article summarizing the findings of the 3rd International Consensus Conference on Image-Detected Breast Cancer. The expert panel suggests that in up to 35% of cases, patients are undergoing unnecessary open surgical biopsies as a first diagnostic procedure when core needle biopsy [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/interesting-consensus-conference-report-on-core-needle-biopsy-of-the-breast/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research on Using Immunohistochemistry to Predict Response to Neoadjuvant Chemotherapy</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-on-using-immunohistochemistry-to-predict-response-to-neoadjuvant-chemotherapy/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-on-using-immunohistochemistry-to-predict-response-to-neoadjuvant-chemotherapy/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 23:37:22 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[immunohistochemistry]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=586</guid>
		<description><![CDATA[In the online &#8220;early view&#8221; section of the journal Cancer there is a new research article proposing that using three currently-used immunohistochemical breast markers in a group of patients who received neoadjuvant chemotherapy, doctors can sub-type cancers similar to those described by molecular profiling.  They also suggest these sub-types are associated with different responses to treatment and overall survival. [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-on-using-immunohistochemistry-to-predict-response-to-neoadjuvant-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NIH State-of-the-Science Conference Statement on Ductal Carcinoma in Situ (DCIS)</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/nih-state-of-the-science-conference-statement-on-ductal-carcinoma-in-situ-dcis/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/nih-state-of-the-science-conference-statement-on-ductal-carcinoma-in-situ-dcis/#comments</comments>
		<pubDate>Fri, 29 Jan 2010 22:38:49 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[lobular carcinoma in situ]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=569</guid>
		<description><![CDATA[There is controversy in the breast health care community about using the term &#8220;carcinoma&#8221; for a non-invasive tumor (DCIS or LCIS).  I want to share with you the abstract from the NIH State-of-the-Science Conference Statement on Ductal Carcinoma in Situ which was just published in the Journal of the National Cancer Institute.  There is a [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/nih-state-of-the-science-conference-statement-on-ductal-carcinoma-in-situ-dcis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Update on Breast Cancer Staging</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/update-on-breast-cancer-staging/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/update-on-breast-cancer-staging/#comments</comments>
		<pubDate>Mon, 18 Jan 2010 03:10:02 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[breast cancer stage]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=561</guid>
		<description><![CDATA[The newest edition of the AJCC&#8217;s Staging Manual is out and there are some changes to breast cancer staging which took effect January 1, 2010.  Several updates in the new edition I felt were good include:
- Moving T0/T1 tumors with only micrometases in the axillary nodes to stage IB from the IIA category.
- Re-affirming the [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/update-on-breast-cancer-staging/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will Molecular Testing Make Grading Breast Cancer Obsolete?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/#comments</comments>
		<pubDate>Thu, 14 Jan 2010 02:35:58 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=540</guid>
		<description><![CDATA[This past October I was at the XXVII Brazilian Society of Pathology meeting in Buzios, Brazil where I was invited to give a few lectures on breast pathology.  I gave one lecture on the traditional grading of breast cancer vs. the new molecular tests that are available. The audience response made me think more on [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research Supporting the Favorable Prognosis of Tubular Carcinoma</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/#comments</comments>
		<pubDate>Thu, 07 Jan 2010 03:33:17 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[invasive ductal carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=532</guid>
		<description><![CDATA[In the January 1, 2010 issue of the Journal of Clinical Oncology, a study was released which confirms the belief that tubular carcinomas of the breast have a more favorable prognosis than typical Grade I invasive carcinomas, NST.
I&#8217;ve reported before on invasive carcinomas which have been associated with a more favorable prognosis.  Tubular carcinoma is [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Importance of Multidisciplinary Breast Care</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/the-importance-of-multidisciplinary-breast-care/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/the-importance-of-multidisciplinary-breast-care/#comments</comments>
		<pubDate>Thu, 17 Dec 2009 02:19:49 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=524</guid>
		<description><![CDATA[Here is a summary by a special panel of the American Society of Breast Disease on the importance of multidisciplinary breast care which addresses gaps in our current process of trying to obtain optimal breast health care for patients.
As a disclaimer, I am a member of the American Society of Breast Disease, but I was not [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/the-importance-of-multidisciplinary-breast-care/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Importance of Specialized Breast Pathology</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/yet-another-reason-we-need-specialized-breast-pathology/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/yet-another-reason-we-need-specialized-breast-pathology/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 23:01:55 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[pathologist]]></category>
		<category><![CDATA[second opinion]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=419</guid>
		<description><![CDATA[I hope you read this article on the importance of having a breast pathologist read your biopsy.  I have posted this before, but it&#8217;s such an important &#8220;white paper&#8221; report from Komen that I think it deserves more discussion.
When confronted with a breast health issue, many patients seek out a particular breast center or a [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/yet-another-reason-we-need-specialized-breast-pathology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Could LCIS Be a Real Cancer and Not Just a Marker of Increased Risk?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/#comments</comments>
		<pubDate>Thu, 30 Oct 2008 17:33:20 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[lobular carcinoma in situ]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=465</guid>
		<description><![CDATA[I&#8217;ve written before about the controversy over lobular carcinoma in situ (LCIS) and whether it is just a marker of increased risk or possibly a precursor to invasive carcinoma, like ductal carcinoma in situ (DCIS). The reason it was felt to be just a marker of increased risk was that most early studies showed that [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Androgen Receptors and Breast Cancer: A New Therapeutic Target?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/#comments</comments>
		<pubDate>Fri, 24 Oct 2008 17:21:20 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[estrogen receptor]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[triple negative]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=449</guid>
		<description><![CDATA[Everyone has heard of the importance of estrogen and progesterone receptors in breast cancer&#8211;but how many of you have heard of the possible role of androgen receptors (AR) in breast cancer?
I have a particular interest in this subject as we published an article several years ago that found AR positivity in 49% of estrogen receptor [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MRI and Partial Breast Irradiation (PBI): New Research</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/#comments</comments>
		<pubDate>Wed, 22 Oct 2008 18:26:30 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=434</guid>
		<description><![CDATA[A study to be released in the November 1 issue of the journal Cancer took a retrospective look at 110 patients with invasive cancer who were involved in a clinical trial on the use of partial breast irradiation (PBI) vs. whole breast irradiation.
MRIs were performed on the patients and the study found that in 10% [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research Data on the Different Subtypes of Invasive Lobular Carcinoma</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-data-on-the-different-subtypes-of-invasive-lobular-carcinoma/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-data-on-the-different-subtypes-of-invasive-lobular-carcinoma/#comments</comments>
		<pubDate>Mon, 20 Oct 2008 02:48:57 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive lobular carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=427</guid>
		<description><![CDATA[Invasive lobular carcinoma (ILC) is the second most common type of breast cancer after invasive carcinoma, no special type (NST).  However, there are several subtypes of ILC, with the pleomorphic variant getting a lot of attention because most studies suggest it behaves in a more aggressive manner than typical ILC. Pathologists also recognize other variants [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-data-on-the-different-subtypes-of-invasive-lobular-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Make Sure You Get The Right Breast Cancer Information From The Web</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/make-sure-you-get-the-right-breast-cancer-information-from-the-web/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/make-sure-you-get-the-right-breast-cancer-information-from-the-web/#comments</comments>
		<pubDate>Sun, 12 Oct 2008 22:10:58 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>
		<category><![CDATA[second opinion]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=381</guid>
		<description><![CDATA[One of the reasons I started this site was to make sure that patients had appropriate information about the pathology behind their breast biopsy diagnosis.  Unfortunately, there is a lot of misinformation out there which has recently come to my attention, thanks to friends and colleagues who I&#8217;ve spoken with.
I have found that there [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/make-sure-you-get-the-right-breast-cancer-information-from-the-web/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does All Atypical Ductal Hyperplasia on Core Biopsy Need to be Excised Surgically?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/does-all-atypical-ductal-hyperplasia-on-core-biopsy-need-to-be-excised-surgically/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/does-all-atypical-ductal-hyperplasia-on-core-biopsy-need-to-be-excised-surgically/#comments</comments>
		<pubDate>Sun, 12 Oct 2008 17:42:16 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[atypical ductal hyperplasia]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[core biopsy]]></category>
		<category><![CDATA[invasive carcinoma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=373</guid>
		<description><![CDATA[The current dogma in the breast community is that a patient with a diagnosis of atypical ductal hyperplasia (ADH) on needle core biopsy needs to have that area removed surgically.  This is because most studies showed that in about 20-30% of the time a more significant lesion was seen on the surgical excision, such as [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/does-all-atypical-ductal-hyperplasia-on-core-biopsy-need-to-be-excised-surgically/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
